Manufacturer
Teva NDC Codes
Finished products listed with the FDA under labeler names that contain “Teva”.
Products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Fluvastatin | Fluvastatin sodium 40 mg/1 | CapsuleOral | Teva Pharmaceuticals USA, Inc. | 0093-7443 |
| Fluvastatin Sodium | Fluvastatin sodium 80 mg/1 | Tablet, Film coated, Extended releaseOral | Teva Pharmaceuticals USA, Inc. | 0093-7446 |
| Formoterol fumarate | Formoterol fumarate 20 ug/2mL | SolutionRespiratory (Inhalation) | Teva Pharmaceuticals USA, Inc. | 0093-4061 |
| Gabapentin | Gabapentin 100 mg/1 | CapsuleOral | Teva Pharmaceuticals, Inc. | 0480-3494 |
| Gefitinib | Gefitinib 250 mg/1 | Tablet, Film coatedOral | Teva Pharmaceuticals, Inc. | 0480-4053 |
| Glipizide and Metformin Hydrochloride | Glipizide 2.5 mg/1; Metformin hydrochloride 250 mg/1 | Tablet, Film coatedOral | Teva Pharmaceuticals USA, Inc. | 0093-7455 |
| Glipizide and Metformin Hydrochloride | Glipizide 2.5 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coatedOral | Teva Pharmaceuticals USA, Inc. | 0093-7456 |
| Glipizide and Metformin Hydrochloride | Glipizide 5 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coatedOral | Teva Pharmaceuticals USA, Inc. | 0093-7457 |
| Glyburide | Glyburide 1.25 mg/1 | TabletOral | Teva Pharmaceuticals USA, Inc. | 0093-8342 |
| Glyburide | Glyburide 2.5 mg/1 | TabletOral | Teva Pharmaceuticals USA, Inc. | 0093-8343 |
| Glyburide | Glyburide 5 mg/1 | TabletOral | Teva Pharmaceuticals USA, Inc. | 0093-8344 |
| Glyburide | Glyburide 5 mg/1 | TabletOral | TEVA Pharmaceuticals USA Inc | 0093-9364 |
| Glyburide | Glyburide 2.5 mg/1 | TabletOral | TEVA Pharmaceuticals USA Inc | 0093-9433 |
| Glyburide | Glyburide 1.25 mg/1 | TabletOral | TEVA Pharmaceuticals USA Inc | 0093-9477 |
| Glycerol phenylbutyrate | Glycerol phenylbutyrate 1.1 g/mL | LiquidOral | Teva Pharmaceuticals, Inc. | 0480-3777 |
| Hydralazine Hydrochloride | Hydralazine hydrochloride 25 mg/1 | TabletOral | Teva Pharmaceuticals USA, Inc. | 50111-327 |
| Hydralazine Hydrochloride | Hydralazine hydrochloride 50 mg/1 | TabletOral | Teva Pharmaceuticals USA, Inc. | 50111-328 |
| Hydralazine Hydrochloride | Hydralazine hydrochloride 100 mg/1 | TabletOral | Teva Pharmaceuticals USA, Inc. | 50111-397 |
| Hydralazine Hydrochloride | Hydralazine hydrochloride 10 mg/1 | TabletOral | Teva Pharmaceuticals USA, Inc. | 50111-398 |
| Hydrochlorothiazide | Hydrochlorothiazide 25 mg/1 | TabletOral | Teva Pharmaceuticals USA, Inc. | 0172-2083 |
| Hydrochlorothiazide | Hydrochlorothiazide 50 mg/1 | TabletOral | Teva Pharmaceuticals USA, Inc. | 0172-2089 |
| Hydrochlorothiazide | Hydrochlorothiazide 12.5 mg/1 | TabletOral | Teva Pharmaceuticals USA, Inc. | 0172-3444 |
| Hydrochlorothiazide | Hydrochlorothiazide 12.5 mg/1 | TabletOral | Teva Pharmaceuticals, Inc. | 0480-3444 |
| Hydromorphone Hydrochloride | Hydromorphone hydrochloride 10 mg/mL | Injection, SolutionIntramuscular, Intravenous, Subcutaneous | Teva Parenteral Medicines, Inc. | 0703-0018 |
| Hydromorphone Hydrochloride | Hydromorphone hydrochloride 10 mg/mL | Injection, SolutionIntramuscular, Intravenous, Subcutaneous | Teva Parenteral Medicines, Inc. | 0703-0110 |